Skip to content
DraconiticResearch
Search Sources API
184,937 studies31 sourcesUpdated 38 min ago
Peer-reviewedCC BY 4.0PLOS One

Computational identification of natural CXCR4-binding candidates relevant to endometriosis and ovarian cancer progression

  1. 1Özel Nev Hospital, Sanliurfa, Türkiye
  2. 2Department of Molecular Biosciences, Faculty of Physical and Biological Sciences, Rashid Latif Khan University, Lahore, Pakistan

Abstract

Endometriosis and ovarian cancer share invasive, inflammatory, and pro-survival mechanisms in which CXCR4 signaling may play an important role, yet phytochemical modulators of this receptor remain insufficiently characterized. This study addressed that gap by integrating receptor reconstruction, ligand-guided docking, pharmacokinetic and toxicity prediction, pharmacophore mapping, density functional theory, replicated membrane-embedded molecular dynamics, and MM/GBSA analysis. A native human CXCR4 model was generated using SWISS-MODEL with 98.2% template coverage and 100% sequence identity, while the co-crystallized IT1t ligand defined the docking cavity. Eighteen phytochemicals were screened, and naringenin achieved the most favorable predicted docking score (−6.361 kcal/mol), exceeding apigenin (−5.927 kcal/mol) and IT1t (−5.155 kcal/mol). Naringenin formed predicted interactions with Tyr116, Arg188, and Tyr255, showed acceptable drug-likeness, solubility, and gastrointestinal absorption, and displayed a wider HOMO–LUMO gap than apigenin. Two independent 100 ns simulations of the CXCR4 complexes with naringenin, apigenin, and IT1t indicated comparatively consistent structural behavior for naringenin, supported by RMSD, SASA, radius of gyration, hydrogen-bond, PCA, FEL, and DCCM analyses. MM/GBSA estimates were also more favorable for naringenin than apigenin across both replicas. Its predicted LD50 was 2000 mg/kg (toxicity class 4), emphasizing that favorable receptor interactions do not establish safety and require experimental toxicological assessment during further preclinical development. Collectively, naringenin emerged as the most coherent in silico prioritized CXCR4-binding candidate. However, the absence of receptor-binding assays, functional validation, and in vivo confirmation remains a major limitation.

Related

  1. Senescence-Associated Transcriptome Reversal Prioritizes Repurposing Candidates for Diabetic Kidney Disease: A Computational Study
    Duygu Aygüneş-Jafari, Zekeriya Düzgün
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Ectopic endometrial stromal cells-derived exosomes accelerate endometriosis progression by delivering PDLIM3 to induce macrophage M2 polarization.
    Chi Chi, Jie Chen, Shuzhen Xiang +5
    Journal of cell communication and signalingPeer-reviewedCC BYFull textObstetrics, gynaecology & paediatricsEurope PMC
  3. Impact of ethanol on odor detection thresholds relevant to No- and Low-Alcohol (NoLo) wines: a combined sensory and computational approach in simplified static hydroalcoholic model wine
    Laura Brian, Anthony Santacreu, Come de Tournadre +6
    Current Research in Food SciencePeer-reviewedCC BY-NC-NDFull textGeneral biologyAnalytical chemistryHAL
  4. Identification of Shared Hub Genes between Endometriosis and Ovarian Clear Cell Carcinoma Using Integrative Bioinformatic Analysis
    Elnaz Zaefari, Zahra Noormohammadi, Ashraf Moini +1
    International Journal of Fertility & SterilityPeer-reviewedCC BY-NC 3.0Full textOncologyPMC
  5. Early identification and prevention of cardiometabolic risk in Gulf Cooperation Council countries: a scoping review relevant to primary care and family medicine.
    Aseel Awad Alsaidan, Bashayer Farhan Alruwaili, Muhannad Almubarak +5
    Preventive medicine reportsPeer-reviewedCC BYFull textEpidemiology & public healthEurope PMC
BibTeX
@article{karagecili2026computational,
  title = {{Computational identification of natural CXCR4-binding candidates relevant to endometriosis and ovarian cancer progression}},
  author = {Sinan Karageçili and Deniz Inan and Nouman Ali},
  journal = {PLOS One},
  year = {2026},
  month = oct,
  doi = {10.1371/journal.pone.0359833},
  url = {https://doi.org/10.1371/journal.pone.0359833},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Computational identification of natural CXCR4-binding candidates relevant to endometriosis and ovarian cancer progression
AU  - Sinan Karageçili
AU  - Deniz Inan
AU  - Nouman Ali
PY  - 2026
DA  - 2026/10/07
JO  - PLOS One
DO  - 10.1371/journal.pone.0359833
UR  - https://doi.org/10.1371/journal.pone.0359833
AB  - Endometriosis and ovarian cancer share invasive, inflammatory, and pro-survival mechanisms in which CXCR4 signaling may play an important role, yet phytochemical modulators of this receptor remain insufficiently characterized. This study addressed that gap by integrating receptor reconstruction, ligand-guided docking, pharmacokinetic and toxicity prediction, pharmacophore mapping, density functional theory, replicated membrane-embedded molecular dynamics, and MM/GBSA analysis. A native human CXCR4 model was generated using SWISS-MODEL with 98.2% template coverage and 100% sequence identity, while the co-crystallized IT1t ligand defined the docking cavity. Eighteen phytochemicals were screened, and naringenin achieved the most favorable predicted docking score (−6.361 kcal/mol), exceeding apigenin (−5.927 kcal/mol) and IT1t (−5.155 kcal/mol). Naringenin formed predicted interactions with Tyr116, Arg188, and Tyr255, showed acceptable drug-likeness, solubility, and gastrointestinal absorption, and displayed a wider HOMO–LUMO gap than apigenin. Two independent 100 ns simulations of the CXCR4 complexes with naringenin, apigenin, and IT1t indicated comparatively consistent structural behavior for naringenin, supported by RMSD, SASA, radius of gyration, hydrogen-bond, PCA, FEL, and DCCM analyses. MM/GBSA estimates were also more favorable for naringenin than apigenin across both replicas. Its predicted LD50 was 2000 mg/kg (toxicity class 4), emphasizing that favorable receptor interactions do not establish safety and require experimental toxicological assessment during further preclinical development. Collectively, naringenin emerged as the most coherent in silico prioritized CXCR4-binding candidate. However, the absence of receptor-binding assays, functional validation, and in vivo confirmation remains a major limitation.
SN  - 1932-6203
ER  -